This information was published on 2025-07-28T08:38:09 for IP Right Registration Published.
| Field | Value |
| (210) | 2546053 (IR 1853070) |
| (220) |
02 Apr 2025
|
| (300) |
US, 21 Oct 2024, 98812003
|
| (511) (510) |
Class 5
Pharmaceutical preparations and substances for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of neuromuscular and cardiac disorders and diseases; anti-inflammatories. |
| (540) | WAYBRI |
| (550) | Word |
| (730) |
Edgewise Therapeutics, Inc.
|
Find out more about publications on the About page.